Occult hepatitis B virus infection in people with haemophilia in South Africa

1. World Health Organization. Global hepatitis report 2024: Action for access in low-and middle-income countries. April 2024. Available from https://www.who.int/publications/i/item/9789240091672 (accessed May 2025). World Health Organization Global hepatitis report 2024: Action for access in low-and middle-income countries April 2024 Available from https://www.who.int/publications/i/item/9789240091672 (accessed May 2025). Search in Google Scholar

2. World Health Organization. Hepatitis B. Available from https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b (accessed May 2025). World Health Organization Hepatitis B Available from https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b (accessed May 2025). Search in Google Scholar

3. Zampino R, Boemio A, Sagnelli C, et al. 2015. Hepatitis B virus burden in developing countries. World J Gastroenterol 2015; 21(42):11941. doi: 10.3748/wjg.v21.i42.11941. ZampinoR BoemioA SagnelliC 2015. Hepatitis B virus burden in developing countries World J Gastroenterol 2015 21 42 11941 10.3748/wjg.v21.i42.11941 Open DOISearch in Google Scholar

4. Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. Lancet 2015; 386(10003):1546–55. doi: 10.1016/S0140-6736(15)61412-X. SchweitzerA HornJ MikolajczykRT Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013 Lancet 2015 386 10003 1546 55 10.1016/S0140-6736(15)61412-X Open DOISearch in Google Scholar

5. Kiire C. The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa. Gut 1996; 38(Suppl 2): S5–12. doi: 10.1136/gut.38.suppl_2.s5. KiireC The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa Gut 1996 38 Suppl 2 S5 12 10.1136/gut.38.suppl_2.s5 Open DOISearch in Google Scholar

6. Kew MC. Hepatitis B virus infection: The burden of disease in South Africa. Southern African Journal of Epidemiology and Infection 2008; 23(1): 4–8. doi: 10.1080/10158782.2008.11441293. KewMC Hepatitis B virus infection: The burden of disease in South Africa Southern African Journal of Epidemiology and Infection 2008 23 1 4 8 10.1080/10158782.2008.11441293 Open DOISearch in Google Scholar

7. Shi Y, Zheng M. Hepatitis B virus persistence and reactivation. BMJ 2020; 370: m2200. doi: https://doi.org/10.1136/bmj.m2200 ShiY ZhengM Hepatitis B virus persistence and reactivation BMJ 2020 370 m2200 doi: https://doi.org/10.1136/bmj.m2200 Search in Google Scholar

8. Yip TCF, Wong GLH. Current knowledge of occult hepatitis B infection and clinical implications. Semin Liver Dis 2019; 39(2): 249–60. doi: 10.1055/s-0039-1678728. YipTCF WongGLH Current knowledge of occult hepatitis B infection and clinical implications Semin Liver Dis 2019 39 2 249 60 10.1055/s-0039-1678728 Open DOISearch in Google Scholar

9. Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol 2019; 71(2):397–408. doi: 10.1016/j.jhep.2019.03.034 RaimondoG LocarniniS PollicinoT Update of the statements on biology and clinical impact of occult hepatitis B virus infection J Hepatol 2019 71 2 397 408 10.1016/j.jhep.2019.03.034 Open DOISearch in Google Scholar

10. Ocana S, Casas ML, Buhigas I, Lledo JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol 2011; 17(12):1553. doi: 10.3748/wjg.v17.i12.1553. OcanaS CasasML BuhigasI LledoJL Diagnostic strategy for occult hepatitis B virus infection World J Gastroenterol 2011 17 12 1553 10.3748/wjg.v17.i12.1553 Open DOISearch in Google Scholar

11. Kramvis A. Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus. S Afr Med J 2018; 108(8):17–21. doi: 10.7196/samj.2018.v108i8.13495. KramvisA Molecular characteristics and clinical relevance of African genotypes and subgenotypes of hepatitis B virus S Afr Med J 2018 108 8 17 21 10.7196/samj.2018.v108i8.13495 Open DOISearch in Google Scholar

12. Hwang EW, Cheung R. Global epidemiology of hepatitis B virus (HBV) infection. North American Journal of Medicine and Science 2011; 4(1):7–13. Available from https://najms.com/index.php/najms/article/view/499 (accessed May 2025). HwangEW CheungR Global epidemiology of hepatitis B virus (HBV) infection North American Journal of Medicine and Science 2011 4 1 7 13 Available from https://najms.com/index.php/najms/article/view/499 (accessed May 2025). Search in Google Scholar

13. Im YR, Jagdish R, Leith D, et al. Prevalence of occult hepatitis B virus infection in adults: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2022; 7(10): 932–42. doi: 10.1016/S2468-1253(22)00201-1. ImYR JagdishR LeithD Prevalence of occult hepatitis B virus infection in adults: A systematic review and meta-analysis Lancet Gastroenterol Hepatol 2022 7 10 932 42 10.1016/S2468-1253(22)00201-1 Open DOISearch in Google Scholar

14. Weusten J, Van Drimmelen H, Vermeulen M, Lelie N. A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios. Transfusion 2017; 57(3pt2): 841–9. doi: 10.1111/trf.14050. WeustenJ Van DrimmelenH VermeulenM LelieN A mathematical model for estimating residual transmission risk of occult hepatitis B virus infection with different blood safety scenarios Transfusion 2017 57 3pt2 841 9 10.1111/trf.14050 Open DOISearch in Google Scholar

15. Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion-transmission risk. Transfus Clin Biol 2017; 24(3): 189–95. doi: 10.1016/j.tracli.2017.06.014. CandottiD BoizeauL LapercheS Occult hepatitis B infection and transfusion-transmission risk Transfus Clin Biol 2017 24 3 189 95 10.1016/j.tracli.2017.06.014 Open DOISearch in Google Scholar

16. Makris M, Preston F, Triger D, et al. Hepatitis c antibody and chronic liver disease in haemophilia. Lancet 1990; 335(8698): 1117–9. doi: 10.1016/0140-6736(90)91124-S. MakrisM PrestonF TrigerD Hepatitis c antibody and chronic liver disease in haemophilia Lancet 1990 335 8698 1117 9 10.1016/0140-6736(90)91124-S Open DOISearch in Google Scholar

17. Merritt EC. Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes. [cited 2024; 2024/08/05]. Available from: https://lordslibrary.parliament.uk/infected-blood-scandal-background-impacts-interim-compensation-and-inquiry-outcomes. MerrittEC Infected blood scandal: Background, impacts, interim compensation and inquiry outcomes. [cited 2024; 2024/08/05] Available from: https://lordslibrary.parliament.uk/infected-blood-scandal-background-impacts-interim-compensation-and-inquiry-outcomes. Search in Google Scholar

18. Teitel JM. Viral safety of haemophilia treatment products. Ann Med 2000; 32(7):485–92. doi: 10.3109/07853890009002024. TeitelJM Viral safety of haemophilia treatment products Ann Med 2000 32 7 485 92 10.3109/07853890009002024 Open DOISearch in Google Scholar

19. Allain JO, Belkhiri D, Vermeulen M, et al. Characterization of occult hepatitis B virus strains in South African blood donors. Hepatology 2009; 49(6): 1868–76. doi: 10.1002/hep.22879. AllainJO BelkhiriD VermeulenM Characterization of occult hepatitis B virus strains in South African blood donors Hepatology 2009 49 6 1868 76 10.1002/hep.22879 Open DOISearch in Google Scholar

20. Bell TG, Makondo E, Martinson NA, Kramvis A. Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: Occult or overt–that is the question. PLoS One 2012; 7(10): e45750. doi: 10.1371/journal.pone.0045750. BellTG MakondoE MartinsonNA KramvisA Hepatitis B virus infection in human immunodeficiency virus infected southern African adults: Occult or overt–that is the question PLoS One 2012 7 10 e45750 10.1371/journal.pone.0045750 Open DOISearch in Google Scholar

21. Msomi N|, Ndlovu K, Gianhari J, et al. High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal, South Africa. J Med Virol 2019; 91(10): 1797–803. doi: 10.1002/jmv.25510. MsomiN NdlovuK GianhariJ High rate of occult hepatitis B virus infection in hemodialysis units of KwaZulu-Natal, South Africa J Med Virol 2019 91 10 1797 803 10.1002/jmv.25510 Open DOISearch in Google Scholar

22. Javanmard D, Namaei MH, Farahmand M, et al. Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia. J Med Virol 2019; 91(8): 1519–27. doi: 10.1002/jmv.25470. JavanmardD NamaeiMH FarahmandM Molecular and serological characterization of occult hepatitis B virus infection among patients with hemophilia J Med Virol 2019 91 8 1519 27 10.1002/jmv.25470 Open DOISearch in Google Scholar

23. Toyoda H, Hayashi K, Murakami Y, et al. Prevalence and clinical implications of occult hepatitis b viral infection in hemophilia patients in Japan. J Med Virol 2004; 73(2): 195–9. doi: 10.1002/jmv.20075. ToyodaH HayashiK MurakamiY Prevalence and clinical implications of occult hepatitis b viral infection in hemophilia patients in Japan J Med Virol 2004 73 2 195 9 10.1002/jmv.20075 Open DOISearch in Google Scholar

24 Varaklioti A, Kouramba A, Ioannidou P, Katsarou O. Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders. Infect Genet Evol 2017; 54: 397–401. doi: 10.1016/j.meegid.2017.07.012. VarakliotiA KourambaA IoannidouP KatsarouO Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders Infect Genet Evol 2017 54 397 401 10.1016/j.meegid.2017.07.012 Open DOISearch in Google Scholar

25. Windyga J, Brojer E, Gronowska A, et al. Preliminary results of HBV DNA testing of Polish haemophilia patients–lack of occult HBV infection. Haemophilia 2006; 12(4): 380–3. doi: 10.1111/j.1365-2516.2006.01293.x. WindygaJ BrojerE GronowskaA Preliminary results of HBV DNA testing of Polish haemophilia patients–lack of occult HBV infection Haemophilia 2006 12 4 380 3 10.1111/j.1365-2516.2006.01293.x Open DOISearch in Google Scholar

26. Spearman CW, Afihene M, Ally R, et al. Hepatitis B in sub-Saharan Africa: Strategies to achieve the 2030 elimination targets. Lancet Gastroenterol Hepatol 2017; 2(12): 900–9. doi: 10.1016/S2468-1253(17)30295-9. SpearmanCW AfiheneM AllyR Hepatitis B in sub-Saharan Africa: Strategies to achieve the 2030 elimination targets Lancet Gastroenterol Hepatol 2017 2 12 900 9 10.1016/S2468-1253(17)30295-9 Open DOISearch in Google Scholar

27. Vermeulen M, Swanevelder R, Van Zyl G, Lelie N, Murphy EL. An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safety. Transfusion 2021; 61(9): 2688–700. doi: 10.1111/trf.16559. VermeulenM SwanevelderR Van ZylG LelieN MurphyEL An assessment of hepatitis B virus prevalence in South African young blood donors born after the implementation of the infant hepatitis B virus immunization program: Implications for transfusion safety Transfusion 2021 61 9 2688 700 10.1111/trf.16559 Open DOISearch in Google Scholar

28. European Medicines Agency. Guideline on plasma-derived medicinal products. 21 July 2011. EMA/CHMP/BWP/706271/2010. Available from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-plasma-derived-medicinal-products_en.pdf (accessed June 2025). European Medicines Agency Guideline on plasma-derived medicinal products 21 July 2011 EMA/CHMP/BWP/706271/2010 Available from https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-plasma-derived-medicinal-products_en.pdf (accessed June 2025). Search in Google Scholar

29. Samal J, Kandpal M. Vivekandandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin Microbiol Rev 2012; 25(1): 142–63. doi: 10.1128/CMR.00018-11. SamalJ KandpalM Vivekandandan P. Molecular mechanisms underlying occult hepatitis B virus infection Clin Microbiol Rev 2012 25 1 142 63 10.1128/CMR.00018-11 Open DOISearch in Google Scholar